Format

Send to

Choose Destination
See comment in PubMed Commons below
Magy Onkol. 2011 Sep;55(3):155-63. doi: MagyOnkol.2011.55.3.155. Epub 2011 Jul 12.

[Treatment and prevention of infections in cancer patients with neutropenia].

[Article in Hungarian]

Author information

1
Fõvárosi Önkormányzat Egyesített Szent István és Szent László Kórház - Rendelõintézet, Budapest, Hungary. janos.sinko@gmail.com

Abstract

Prognosis of malignant diseases is significantly influenced by infectious morbidity and mortality. Thus, up to date management of cancer patients, in addition to other supportive care modalities, should also incorporate diagnostic methods and therapy of infections. In order to improve outcome, patients developing febrile neutropenia following antitumour treatment should be adequately informed regarding the risk of infections. At the same time, centres responsible for cancer patient care should set up written protocols for basic workup and empirical antibiotic therapy. Here general characteristics of neutropenic infections developing in solid tumour patients are outlined and key points for risk assessment are highlighted. In addition, options and limits of anti-infective therapy as well as prophylaxis of infections are reviewed. Importance of a fully functional institutional infection control system and multidisciplinary patient management is also emphasised.

PMID:
21918740
DOI:
MagyOnkol.2011.55.3.155
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hungarian Oncological Association
    Loading ...
    Support Center